Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy

Autores
Debes, Jose D.; Chan, Aaron J.; Balderramo, Domingo; Kikuchi, Luciana; Gonzalez Ballerga, Esteban; Prieto, Jhon E.; Tapias, Monica; Idrovo, Victor; Davalos, Milagros B.; Cairo, Fernando; Barreyro, Fernando Javier; Paredes, Mario Sebastian; Hernandez, Nelia; Avendaño, Karla; Diaz Ferrer, Javier; Yang, Ju Dong; Carrera, Enrique; Garcia, Jairo A.; Mattos, Angelo Z.; Hirsch, Bruno S.; Gonçalves, Pablo T.; Carrilho, Flair J.; Roberts, Lewis R.
Año de publicación
2017
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Background & Aims: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. Most studies addressing the epidemiology of HCC originate from developed countries. This study reports the preliminary findings of a multinational approach to characterize HCC in South America. Methods: We evaluated 1336 HCC patients seen at 14 centres in six South American countries using a retrospective study design with participating centres completing a template chart of patient characteristics. The diagnosis of HCC was made radiographically or histologically for all cases according to institutional standards. Methodology of surveillance for each centre was following AASLD or EASL recommendations. Results: Sixty-eight percent of individuals were male with a median age of 64 years at time of diagnosis. The most common risk factor for HCC was hepatitis C infection (HCV, 48%), followed by alcoholic cirrhosis (22%), Hepatitis B infection (HBV, 14%) and NAFLD (9%). We found that among individuals with HBV-related HCC, 38% were diagnosed before age 50. The most commonly provided therapy was transarterial chemoembolization (35% of HCCs) with few individuals being considered for liver transplant (<20%). Only 47% of HCCs were diagnosed during surveillance, and there was no difference in age of diagnosis between those diagnosed incidentally vs by surveillance. Nonetheless, being diagnosed during surveillance was associated with improved overall survival (P = .01). Conclusions: Our study represents the largest cohort to date reporting characteristics and outcomes of HCC across South America. We found an important number of HCCs diagnosed outside of surveillance programmes, with associated increased mortality in those patients.
Fil: Debes, Jose D.. University of Minnesota; Estados Unidos
Fil: Chan, Aaron J.. University of Minnesota; Estados Unidos
Fil: Balderramo, Domingo. Instituto Universitario de Ciencias Biomédicas de Córdoba; Argentina
Fil: Kikuchi, Luciana. Universidade de Sao Paulo; Brasil
Fil: Gonzalez Ballerga, Esteban. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
Fil: Prieto, Jhon E.. Organización Sanitas; Colombia. Centro de Enfermedades Hepáticas y Digestivas; Colombia
Fil: Tapias, Monica. Organización Sanitas; Colombia. Fundación Santa Fe de Bogotá. Hospital Universitario; Colombia
Fil: Idrovo, Victor. Organización Sanitas; Colombia. Fundación Santa Fe de Bogotá. Hospital Universitario; Colombia
Fil: Davalos, Milagros B.. Hospital Nacional Edgardo Rebagliati Martins; Perú
Fil: Cairo, Fernando. Provincia de Buenos Aires. Ministerio de Salud. Hospital Alta Complejidad en Red El Cruce Dr. Néstor Carlos Kirchner Samic; Argentina
Fil: Barreyro, Fernando Javier. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste; Argentina
Fil: Paredes, Mario Sebastian. Provincia de Formosa. Ministerio de Salud. Hospital de Alta Complejidad "Pte. Juan Domingo Perón"; Argentina
Fil: Hernandez, Nelia. Universidad de la República; Uruguay
Fil: Avendaño, Karla. Universidad de la República; Uruguay
Fil: Diaz Ferrer, Javier. Hospital Nacional Edgardo Rebagliati Martins; Perú
Fil: Yang, Ju Dong. Mayo Clinic College of Medicine & Science; Estados Unidos
Fil: Carrera, Enrique. Hospital Eugenio Espejo; Ecuador
Fil: Garcia, Jairo A.. Fundación Valle del Lili; Colombia
Fil: Mattos, Angelo Z.. Hospital Nossa Senhora da Conceição; Brasil
Fil: Hirsch, Bruno S.. Hospital Nossa Senhora da Conceição; Brasil
Fil: Gonçalves, Pablo T.. Hospital Nossa Senhora da Conceição; Brasil
Fil: Carrilho, Flair J.. Universidade de Sao Paulo; Brasil
Fil: Roberts, Lewis R.. Mayo Clinic College of Medicine & Science; Estados Unidos
Materia
Demographics
Hepatocellular Carcinoma
Risk Factors
South America
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/41491

id CONICETDig_fb4e78f9e36031b620c893435639302c
oai_identifier_str oai:ri.conicet.gov.ar:11336/41491
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapyDebes, Jose D.Chan, Aaron J.Balderramo, DomingoKikuchi, LucianaGonzalez Ballerga, EstebanPrieto, Jhon E.Tapias, MonicaIdrovo, VictorDavalos, Milagros B.Cairo, FernandoBarreyro, Fernando JavierParedes, Mario SebastianHernandez, NeliaAvendaño, KarlaDiaz Ferrer, JavierYang, Ju DongCarrera, EnriqueGarcia, Jairo A.Mattos, Angelo Z.Hirsch, Bruno S.Gonçalves, Pablo T.Carrilho, Flair J.Roberts, Lewis R.DemographicsHepatocellular CarcinomaRisk FactorsSouth Americahttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Background & Aims: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. Most studies addressing the epidemiology of HCC originate from developed countries. This study reports the preliminary findings of a multinational approach to characterize HCC in South America. Methods: We evaluated 1336 HCC patients seen at 14 centres in six South American countries using a retrospective study design with participating centres completing a template chart of patient characteristics. The diagnosis of HCC was made radiographically or histologically for all cases according to institutional standards. Methodology of surveillance for each centre was following AASLD or EASL recommendations. Results: Sixty-eight percent of individuals were male with a median age of 64 years at time of diagnosis. The most common risk factor for HCC was hepatitis C infection (HCV, 48%), followed by alcoholic cirrhosis (22%), Hepatitis B infection (HBV, 14%) and NAFLD (9%). We found that among individuals with HBV-related HCC, 38% were diagnosed before age 50. The most commonly provided therapy was transarterial chemoembolization (35% of HCCs) with few individuals being considered for liver transplant (<20%). Only 47% of HCCs were diagnosed during surveillance, and there was no difference in age of diagnosis between those diagnosed incidentally vs by surveillance. Nonetheless, being diagnosed during surveillance was associated with improved overall survival (P = .01). Conclusions: Our study represents the largest cohort to date reporting characteristics and outcomes of HCC across South America. We found an important number of HCCs diagnosed outside of surveillance programmes, with associated increased mortality in those patients.Fil: Debes, Jose D.. University of Minnesota; Estados UnidosFil: Chan, Aaron J.. University of Minnesota; Estados UnidosFil: Balderramo, Domingo. Instituto Universitario de Ciencias Biomédicas de Córdoba; ArgentinaFil: Kikuchi, Luciana. Universidade de Sao Paulo; BrasilFil: Gonzalez Ballerga, Esteban. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; ArgentinaFil: Prieto, Jhon E.. Organización Sanitas; Colombia. Centro de Enfermedades Hepáticas y Digestivas; ColombiaFil: Tapias, Monica. Organización Sanitas; Colombia. Fundación Santa Fe de Bogotá. Hospital Universitario; ColombiaFil: Idrovo, Victor. Organización Sanitas; Colombia. Fundación Santa Fe de Bogotá. Hospital Universitario; ColombiaFil: Davalos, Milagros B.. Hospital Nacional Edgardo Rebagliati Martins; PerúFil: Cairo, Fernando. Provincia de Buenos Aires. Ministerio de Salud. Hospital Alta Complejidad en Red El Cruce Dr. Néstor Carlos Kirchner Samic; ArgentinaFil: Barreyro, Fernando Javier. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste; ArgentinaFil: Paredes, Mario Sebastian. Provincia de Formosa. Ministerio de Salud. Hospital de Alta Complejidad "Pte. Juan Domingo Perón"; ArgentinaFil: Hernandez, Nelia. Universidad de la República; UruguayFil: Avendaño, Karla. Universidad de la República; UruguayFil: Diaz Ferrer, Javier. Hospital Nacional Edgardo Rebagliati Martins; PerúFil: Yang, Ju Dong. Mayo Clinic College of Medicine & Science; Estados UnidosFil: Carrera, Enrique. Hospital Eugenio Espejo; EcuadorFil: Garcia, Jairo A.. Fundación Valle del Lili; ColombiaFil: Mattos, Angelo Z.. Hospital Nossa Senhora da Conceição; BrasilFil: Hirsch, Bruno S.. Hospital Nossa Senhora da Conceição; BrasilFil: Gonçalves, Pablo T.. Hospital Nossa Senhora da Conceição; BrasilFil: Carrilho, Flair J.. Universidade de Sao Paulo; BrasilFil: Roberts, Lewis R.. Mayo Clinic College of Medicine & Science; Estados UnidosWiley Blackwell Publishing, Inc2017-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/41491Debes, Jose D.; Chan, Aaron J.; Balderramo, Domingo; Kikuchi, Luciana; Gonzalez Ballerga, Esteban; et al.; Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy; Wiley Blackwell Publishing, Inc; Liver International; 38; 1; 6-2017; 136-1431478-3223CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1111/liv.13502info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1111/liv.13502info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:46:20Zoai:ri.conicet.gov.ar:11336/41491instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:46:20.261CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy
title Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy
spellingShingle Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy
Debes, Jose D.
Demographics
Hepatocellular Carcinoma
Risk Factors
South America
title_short Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy
title_full Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy
title_fullStr Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy
title_full_unstemmed Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy
title_sort Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy
dc.creator.none.fl_str_mv Debes, Jose D.
Chan, Aaron J.
Balderramo, Domingo
Kikuchi, Luciana
Gonzalez Ballerga, Esteban
Prieto, Jhon E.
Tapias, Monica
Idrovo, Victor
Davalos, Milagros B.
Cairo, Fernando
Barreyro, Fernando Javier
Paredes, Mario Sebastian
Hernandez, Nelia
Avendaño, Karla
Diaz Ferrer, Javier
Yang, Ju Dong
Carrera, Enrique
Garcia, Jairo A.
Mattos, Angelo Z.
Hirsch, Bruno S.
Gonçalves, Pablo T.
Carrilho, Flair J.
Roberts, Lewis R.
author Debes, Jose D.
author_facet Debes, Jose D.
Chan, Aaron J.
Balderramo, Domingo
Kikuchi, Luciana
Gonzalez Ballerga, Esteban
Prieto, Jhon E.
Tapias, Monica
Idrovo, Victor
Davalos, Milagros B.
Cairo, Fernando
Barreyro, Fernando Javier
Paredes, Mario Sebastian
Hernandez, Nelia
Avendaño, Karla
Diaz Ferrer, Javier
Yang, Ju Dong
Carrera, Enrique
Garcia, Jairo A.
Mattos, Angelo Z.
Hirsch, Bruno S.
Gonçalves, Pablo T.
Carrilho, Flair J.
Roberts, Lewis R.
author_role author
author2 Chan, Aaron J.
Balderramo, Domingo
Kikuchi, Luciana
Gonzalez Ballerga, Esteban
Prieto, Jhon E.
Tapias, Monica
Idrovo, Victor
Davalos, Milagros B.
Cairo, Fernando
Barreyro, Fernando Javier
Paredes, Mario Sebastian
Hernandez, Nelia
Avendaño, Karla
Diaz Ferrer, Javier
Yang, Ju Dong
Carrera, Enrique
Garcia, Jairo A.
Mattos, Angelo Z.
Hirsch, Bruno S.
Gonçalves, Pablo T.
Carrilho, Flair J.
Roberts, Lewis R.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Demographics
Hepatocellular Carcinoma
Risk Factors
South America
topic Demographics
Hepatocellular Carcinoma
Risk Factors
South America
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Background & Aims: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. Most studies addressing the epidemiology of HCC originate from developed countries. This study reports the preliminary findings of a multinational approach to characterize HCC in South America. Methods: We evaluated 1336 HCC patients seen at 14 centres in six South American countries using a retrospective study design with participating centres completing a template chart of patient characteristics. The diagnosis of HCC was made radiographically or histologically for all cases according to institutional standards. Methodology of surveillance for each centre was following AASLD or EASL recommendations. Results: Sixty-eight percent of individuals were male with a median age of 64 years at time of diagnosis. The most common risk factor for HCC was hepatitis C infection (HCV, 48%), followed by alcoholic cirrhosis (22%), Hepatitis B infection (HBV, 14%) and NAFLD (9%). We found that among individuals with HBV-related HCC, 38% were diagnosed before age 50. The most commonly provided therapy was transarterial chemoembolization (35% of HCCs) with few individuals being considered for liver transplant (<20%). Only 47% of HCCs were diagnosed during surveillance, and there was no difference in age of diagnosis between those diagnosed incidentally vs by surveillance. Nonetheless, being diagnosed during surveillance was associated with improved overall survival (P = .01). Conclusions: Our study represents the largest cohort to date reporting characteristics and outcomes of HCC across South America. We found an important number of HCCs diagnosed outside of surveillance programmes, with associated increased mortality in those patients.
Fil: Debes, Jose D.. University of Minnesota; Estados Unidos
Fil: Chan, Aaron J.. University of Minnesota; Estados Unidos
Fil: Balderramo, Domingo. Instituto Universitario de Ciencias Biomédicas de Córdoba; Argentina
Fil: Kikuchi, Luciana. Universidade de Sao Paulo; Brasil
Fil: Gonzalez Ballerga, Esteban. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
Fil: Prieto, Jhon E.. Organización Sanitas; Colombia. Centro de Enfermedades Hepáticas y Digestivas; Colombia
Fil: Tapias, Monica. Organización Sanitas; Colombia. Fundación Santa Fe de Bogotá. Hospital Universitario; Colombia
Fil: Idrovo, Victor. Organización Sanitas; Colombia. Fundación Santa Fe de Bogotá. Hospital Universitario; Colombia
Fil: Davalos, Milagros B.. Hospital Nacional Edgardo Rebagliati Martins; Perú
Fil: Cairo, Fernando. Provincia de Buenos Aires. Ministerio de Salud. Hospital Alta Complejidad en Red El Cruce Dr. Néstor Carlos Kirchner Samic; Argentina
Fil: Barreyro, Fernando Javier. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste; Argentina
Fil: Paredes, Mario Sebastian. Provincia de Formosa. Ministerio de Salud. Hospital de Alta Complejidad "Pte. Juan Domingo Perón"; Argentina
Fil: Hernandez, Nelia. Universidad de la República; Uruguay
Fil: Avendaño, Karla. Universidad de la República; Uruguay
Fil: Diaz Ferrer, Javier. Hospital Nacional Edgardo Rebagliati Martins; Perú
Fil: Yang, Ju Dong. Mayo Clinic College of Medicine & Science; Estados Unidos
Fil: Carrera, Enrique. Hospital Eugenio Espejo; Ecuador
Fil: Garcia, Jairo A.. Fundación Valle del Lili; Colombia
Fil: Mattos, Angelo Z.. Hospital Nossa Senhora da Conceição; Brasil
Fil: Hirsch, Bruno S.. Hospital Nossa Senhora da Conceição; Brasil
Fil: Gonçalves, Pablo T.. Hospital Nossa Senhora da Conceição; Brasil
Fil: Carrilho, Flair J.. Universidade de Sao Paulo; Brasil
Fil: Roberts, Lewis R.. Mayo Clinic College of Medicine & Science; Estados Unidos
description Background & Aims: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. Most studies addressing the epidemiology of HCC originate from developed countries. This study reports the preliminary findings of a multinational approach to characterize HCC in South America. Methods: We evaluated 1336 HCC patients seen at 14 centres in six South American countries using a retrospective study design with participating centres completing a template chart of patient characteristics. The diagnosis of HCC was made radiographically or histologically for all cases according to institutional standards. Methodology of surveillance for each centre was following AASLD or EASL recommendations. Results: Sixty-eight percent of individuals were male with a median age of 64 years at time of diagnosis. The most common risk factor for HCC was hepatitis C infection (HCV, 48%), followed by alcoholic cirrhosis (22%), Hepatitis B infection (HBV, 14%) and NAFLD (9%). We found that among individuals with HBV-related HCC, 38% were diagnosed before age 50. The most commonly provided therapy was transarterial chemoembolization (35% of HCCs) with few individuals being considered for liver transplant (<20%). Only 47% of HCCs were diagnosed during surveillance, and there was no difference in age of diagnosis between those diagnosed incidentally vs by surveillance. Nonetheless, being diagnosed during surveillance was associated with improved overall survival (P = .01). Conclusions: Our study represents the largest cohort to date reporting characteristics and outcomes of HCC across South America. We found an important number of HCCs diagnosed outside of surveillance programmes, with associated increased mortality in those patients.
publishDate 2017
dc.date.none.fl_str_mv 2017-06
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/41491
Debes, Jose D.; Chan, Aaron J.; Balderramo, Domingo; Kikuchi, Luciana; Gonzalez Ballerga, Esteban; et al.; Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy; Wiley Blackwell Publishing, Inc; Liver International; 38; 1; 6-2017; 136-143
1478-3223
CONICET Digital
CONICET
url http://hdl.handle.net/11336/41491
identifier_str_mv Debes, Jose D.; Chan, Aaron J.; Balderramo, Domingo; Kikuchi, Luciana; Gonzalez Ballerga, Esteban; et al.; Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy; Wiley Blackwell Publishing, Inc; Liver International; 38; 1; 6-2017; 136-143
1478-3223
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1111/liv.13502
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1111/liv.13502
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Wiley Blackwell Publishing, Inc
publisher.none.fl_str_mv Wiley Blackwell Publishing, Inc
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842268786949881856
score 13.13397